-
1
-
-
29244463365
-
Astrocyte-endothelial interactions at the blood-brain barrier
-
DOI 10.1038/nrn1824
-
Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41-53 (Pubitemid 41828930)
-
(2006)
Nature Reviews Neuroscience
, vol.7
, Issue.1
, pp. 41-53
-
-
Abbott, N.J.1
Ronnback, L.2
Hansson, E.3
-
3
-
-
38049174887
-
Endothelial cells constituting blood-nerve barrier have highly specialized characteristics as barrier-forming cells
-
DOI 10.1247/csf.07015
-
Sano Y, Shimizu F, Nakayama H, Abe M, Maeda T, Ohtsuki S, Terasaki T, Obinata M, Ueda M, Takahashi R, Kanda T (2007) Endothelial cells constituting blood-nerve barrier have highly specialized characteristics as barrier-forming cells. Cell Struct Funct 32:139-147 (Pubitemid 351483586)
-
(2007)
Cell Structure and Function
, vol.32
, Issue.2
, pp. 139-147
-
-
Sano, Y.1
Shimizu, F.2
Nakayama, H.3
Abe, M.4
Maeda, T.5
Ohtsuki, S.6
Terasaki, T.7
Obinata, M.8
Ueda, M.9
Takahashi, R.-I.10
Kanda, T.11
-
5
-
-
0035195970
-
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
-
DOI 10.1007/s001250100001
-
Cameron NE, Eaton SE, Cotter MA, Tesfaye S (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973-1988 (Pubitemid 33124042)
-
(2001)
Diabetologia
, vol.44
, Issue.11
, pp. 1973-1988
-
-
Cameron, N.E.1
Eaton, S.E.M.2
Cotter, M.A.3
Tesfaye, S.4
-
6
-
-
0028928433
-
Basement membrane reduplication and pericyte degeneration precede development of diabeticpolyneuropathy and are associated with its severity
-
Giannini C, Dyck PJ (1995) Basement membrane reduplication and pericyte degeneration precede development of diabeticpolyneuropathy and are associated with its severity. Ann Neurol 37:498-504
-
(1995)
Ann Neurol
, vol.37
, pp. 498-504
-
-
Giannini, C.1
Dyck, P.J.2
-
7
-
-
0030639225
-
Regulation of capillary formation by laminin and other components of the extracellular matrix
-
Grant DS, Kleinman HK (1997) Regulation of capillary formation by laminin and other components of the extracellular matrix. EXS 79:317-333
-
(1997)
EXS
, vol.79
, pp. 317-333
-
-
Grant, D.S.1
Kleinman, H.K.2
-
8
-
-
0037209457
-
Expression and adhesive properties of basementmembrane proteins in cerebral capillary endothelial cell cultures
-
Tilling T, Engelbertz C, Decker S, Korte D, Hüwel S, Galla HJ (2002) Expression and adhesive properties of basementmembrane proteins in cerebral capillary endothelial cell cultures. Cell Tissue Res 310:19-29
-
(2002)
Cell Tissue Res
, vol.310
, pp. 19-29
-
-
Tilling, T.1
Engelbertz, C.2
Decker, S.3
Korte, D.4
Hüwel, S.5
Galla, H.J.6
-
9
-
-
33644683263
-
Endothelial extracellular matrix: Biosynthesis, remodeling, and functions during vascularmorphogenesis and neovessel stabilization
-
Davis GE, Senger DR (2005) Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascularmorphogenesis and neovessel stabilization. Circ Res 97:1093-1107
-
(2005)
Circ Res
, vol.97
, pp. 1093-1107
-
-
Davis, G.E.1
Senger, D.R.2
-
10
-
-
0028141655
-
Astrocytes modulate retinal vasculogenesis: Effects on fibronectin expression
-
Jiang B, Liou GI, Behzadian MA, Caldwell RB (1994) Astrocytes modulate retinal vasculogenesis: effects on fibronectin expression. J Cell Sci 107:2499-2508 (Pubitemid 24292498)
-
(1994)
Journal of Cell Science
, vol.107
, Issue.9
, pp. 2499-2508
-
-
Jiang, B.1
Liou, G.I.2
Behzadian, M.A.3
Caldwell, R.B.4
-
11
-
-
34848841846
-
Altered expression of basement membrane-related molecules in rat brain pericyte, endothelial, and astrocyte cell lines after transforming growth factor-beta1 treatment
-
Kose N, Asashima T, Muta M, Iizasa H, Sai Y, Terasaki T, Nakashima E (2007) Altered expression of basement membrane-related molecules in rat brain pericyte, endothelial, and astrocyte cell lines after transforming growth factor-beta1 treatment. Drug Metab Pharmacokinet 22:255-266
-
(2007)
Drug Metab Pharmacokinet
, vol.22
, pp. 255-266
-
-
Kose, N.1
Asashima, T.2
Muta, M.3
Iizasa, H.4
Sai, Y.5
Terasaki, T.6
Nakashima, E.7
-
12
-
-
33746920337
-
Advanced glycation end products: Sparking the development of diabetic vascular injury
-
DOI 10.1161/CIRCULATIONAHA.106.621854, PII 0000301720060808000013
-
Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:597-605 (Pubitemid 44199649)
-
(2006)
Circulation
, vol.114
, Issue.6
, pp. 597-605
-
-
Goldin, A.1
Beckman, J.A.2
Schmidt, A.M.3
Creager, M.A.4
-
13
-
-
47849127561
-
Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers
-
Ban CR, Twigg SM (2008) Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag 4:575-596 (Pubitemid 352037917)
-
(2008)
Vascular Health and Risk Management
, vol.4
, Issue.3
, pp. 575-596
-
-
Ban, C.R.1
Twigg, S.M.2
-
14
-
-
34247354628
-
Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes
-
Canning P, Glenn JV, Hsu DK, Liu FT, Gardiner TA, Stitt AW (2007) Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes. Exp Diabetes Res: 51837
-
(2007)
Exp Diabetes Res
, pp. 51837
-
-
Canning, P.1
Glenn, J.V.2
Hsu, D.K.3
Liu, F.T.4
Gardiner, T.A.5
Stitt, A.W.6
-
15
-
-
78049231404
-
Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors
-
Shimizu F, Sano Y, Abe MA, Maeda T, Ohtsuki S, Terasaki T, Obinata M, Kanda T (2011) Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors. J Cell Physiol 226:255-266
-
(2011)
J Cell Physiol
, vol.226
, pp. 255-266
-
-
Shimizu, F.1
Sano, Y.2
Abe, M.A.3
Maeda, T.4
Ohtsuki, S.5
Terasaki, T.6
Obinata, M.7
Kanda, T.8
-
16
-
-
51449091353
-
Peripheral nerve pericytes originating from the blood-nerve barrier expresses tight junctional molecules and transporters as barrier-forming cells
-
Shimizu F, Sano Y, Maeda T, Abe MA, Nakayama H, Takahashi R, Ueda M, Ohtsuki S, Terasaki T, Obinata M, Kanda T (2008) Peripheral nerve pericytes originating from the blood-nerve barrier expresses tight junctional molecules and transporters as barrier-forming cells. J Cell Physiol 217:388-399
-
(2008)
J Cell Physiol
, vol.217
, pp. 388-399
-
-
Shimizu, F.1
Sano, Y.2
Maeda, T.3
Abe, M.A.4
Nakayama, H.5
Takahashi, R.6
Ueda, M.7
Ohtsuki, S.8
Terasaki, T.9
Obinata, M.10
Kanda, T.11
-
17
-
-
0037197736
-
Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes
-
DOI 10.1016/S0169-328X(02)00132-8, PII S0169328X02001328
-
Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, Rogers JH (2002) Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res Mol Brain Res 100:103-117 (Pubitemid 34465583)
-
(2002)
Molecular Brain Research
, vol.100
, Issue.1-2
, pp. 103-117
-
-
Muir, E.M.1
Adcock, K.H.2
Morgenstern, D.A.3
Clayton, R.4
Von Stillfried, N.5
Rhodes, K.6
Ellis, C.7
Fawcett, J.W.8
Rogers, J.H.9
-
18
-
-
0031914414
-
Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: Involvement of the transforming growth factor-beta system
-
DOI 10.1046/j.1523-1755.1998.00815.x
-
Ziyadeh FN, Han DC, Cohen JA, Guo J, Cohen MP (1998) Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system. Kidney Int 53:631-638 (Pubitemid 28124277)
-
(1998)
Kidney International
, vol.53
, Issue.3
, pp. 631-638
-
-
Ziyadeh, F.N.1
Han, D.C.2
Cohen, J.A.3
Guo, J.4
Cohen, M.P.5
-
19
-
-
0029076281
-
Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator
-
Sharma K, Ziyadeh FN (1995) Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-1146
-
(1995)
Diabetes
, vol.44
, pp. 1139-1146
-
-
Sharma, K.1
Ziyadeh, F.N.2
-
20
-
-
0029924637
-
Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice
-
Sharma K, Jin Y, Guo J, Ziyadeh FN (1996) Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530
-
(1996)
Diabetes
, vol.45
, pp. 522-530
-
-
Sharma, K.1
Jin, Y.2
Guo, J.3
Ziyadeh, F.N.4
-
21
-
-
0034608948
-
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice
-
Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K (2000) Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97:8015-8020
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 8015-8020
-
-
Ziyadeh, F.N.1
Hoffman, B.B.2
Han, D.C.3
Iglesias-De La Cruz, M.C.4
Hong, S.W.5
Isono, M.6
Chen, S.7
McGowan, T.A.8
Sharma, K.9
-
22
-
-
33750713086
-
Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice
-
Sung SH, Ziyadeh FN, Wang A, Pyagay PE, Kanwar YS, Chen S (2006) Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 17:3093-310423.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 3093-310423
-
-
Sung, S.H.1
Ziyadeh, F.N.2
Wang, A.3
Pyagay, P.E.4
Kanwar, Y.S.5
Chen, S.6
-
23
-
-
48549088705
-
Vascular endothelial growth factor in eye disease
-
Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME (2008) Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 27:331-371
-
(2008)
Prog Retin Eye Res
, vol.27
, pp. 331-371
-
-
Penn, J.S.1
Madan, A.2
Caldwell, R.B.3
Bartoli, M.4
Caldwell, R.W.5
Hartnett, M.E.6
-
24
-
-
23744467294
-
Role of advanced glycation end products and their receptors in development of diabetic neuropathy
-
DOI 10.1196/annals.1338.067
-
Wada R, Yagihashi S (2005) Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann NYAcad Sci 1043:598-604 (Pubitemid 41123949)
-
(2005)
Annals of the New York Academy of Sciences
, vol.1043
, pp. 598-604
-
-
Wada, R.1
Yagihashi, S.2
-
25
-
-
0031451560
-
Localization in human diabetic peripheral nerve of N(epsilon)- carboxymethyllysine-protein adducts, an advanced glycation endproduct
-
DOI 10.1007/s001250050839
-
Sugimoto K, Nishizawa Y, Horiuchi S, Yagihashi S (1997) Localization in human diabetic peripheral nerve of N(epsilon)- carboxymethyllysine-protein adducts, an advanced glycation end-product. Diabetologia 40:1380-1387 (Pubitemid 28004930)
-
(1997)
Diabetologia
, vol.40
, Issue.12
, pp. 1380-1387
-
-
Sugimoto, K.1
Nishizawa, Y.2
Horiuchi, S.3
Yagihashi, S.4
-
26
-
-
0037899247
-
Microvascular basement membranes in diabetes mellitus
-
Tsilibary EC (2003) Microvascular basement membranes in diabetes mellitus. J Pathol 200:537-546
-
(2003)
J Pathol
, vol.200
, pp. 537-546
-
-
Tsilibary, E.C.1
-
27
-
-
41149155362
-
Cellular signaling and potential new treatment targets in diabetic retinopathy
-
Khan ZA, Chakrabarti S (2007) Cellular signaling and potential new treatment targets in diabetic retinopathy. Exp Diabetes Res. 31867
-
(2007)
Exp Diabetes Res
, pp. 31867
-
-
Khan, Z.A.1
Chakrabarti, S.2
-
28
-
-
0033733768
-
Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats
-
Stitt AW, Bhaduri T, McMullen CB, Gardiner TA, Archer DB (2000) Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats. Mol Cell Biol Res Commun 3:380-388
-
(2000)
Mol Cell Biol Res Commun
, vol.3
, pp. 380-388
-
-
Stitt, A.W.1
Bhaduri, T.2
McMullen, C.B.3
Gardiner, T.A.4
Archer, D.B.5
-
29
-
-
0032520871
-
Advanced glycation end products increase retinal vascular endothelial growth factor expression
-
Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP (1998) Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 101:1219-1224 (Pubitemid 28145237)
-
(1998)
Journal of Clinical Investigation
, vol.101
, Issue.6
, pp. 1219-1224
-
-
Lu, M.1
Kuroki, M.2
Amano, S.3
Tolentino, M.4
Keough, K.5
Kim, I.6
Bucala, R.7
Adamis, A.P.8
-
30
-
-
17144457576
-
Advanced glycation end products-driven angiogenesis in vitro: Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor
-
DOI 10.1074/jbc.272.13.8723
-
Yamagishi S, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, NomuraM, Yamamoto H (1997) Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 272:8723-8730 (Pubitemid 27147841)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.13
, pp. 8723-8730
-
-
Yamagishi, S.-I.1
Yonekura, H.2
Yamamoto, Y.3
Katsuno, K.4
Sato, F.5
Mita, I.6
Ooka, H.7
Satozawa, N.8
Kawakami, T.9
Nomura, M.10
Yamamoto, H.11
-
31
-
-
11144267118
-
Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epithelium
-
DOI 10.1136/bjo.2004.045914
-
McFarlane S, Glenn JV, Lichanska AM, Simpson DA, Stitt AW (2005) Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epithelium. Br J Ophthalmol 89:107-112 (Pubitemid 40040249)
-
(2005)
British Journal of Ophthalmology
, vol.89
, Issue.1
, pp. 107-112
-
-
McFarlane, S.1
Glenn, J.V.2
Lichanska, A.M.3
Simpson, D.A.C.4
Stitt, A.W.5
-
32
-
-
74449092465
-
The inhibition of advanced glycation end-products-induced retinal vascular permeability by silver nanoparticles
-
Sheikpranbabu S, Kalishwaralal K, Lee KJ, Vaidyanathan R, Eom SH, Gurunathan S (2010) The inhibition of advanced glycation end-products-induced retinal vascular permeability by silver nanoparticles. Biomaterials 31:2260-2271
-
(2010)
Biomaterials
, vol.31
, pp. 2260-2271
-
-
Sheikpranbabu, S.1
Kalishwaralal, K.2
Lee, K.J.3
Vaidyanathan, R.4
Eom, S.H.5
Gurunathan, S.6
-
33
-
-
0037648580
-
Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice
-
DOI 10.1083/jcb.200302070
-
Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161:653-660 (Pubitemid 36578587)
-
(2003)
Journal of Cell Biology
, vol.161
, Issue.3
, pp. 653-660
-
-
Nitta, T.1
Hata, M.2
Gotoh, S.3
Seo, Y.4
Sasaki, H.5
Hashimoto, N.6
Furuse, M.7
Tsukita, S.8
-
34
-
-
70349161964
-
RAGE, vascular tone and vascular disease
-
Farmer DG, Kennedy S (2009) RAGE, vascular tone and vascular disease. Pharmacol Ther 124:185-194
-
(2009)
Pharmacol Ther
, vol.124
, pp. 185-194
-
-
Farmer, D.G.1
Kennedy, S.2
-
35
-
-
17144430517
-
Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury
-
DOI 10.1254/jphs.CPJ04005X
-
Yonekura H, Yamamoto Y, Sakurai S, Watanabe T, Yamamoto H (2005) Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury. J Pharmacol Sci 97:305-311 (Pubitemid 40515743)
-
(2005)
Journal of Pharmacological Sciences
, vol.97
, Issue.3
, pp. 305-311
-
-
Yonekura, H.1
Yamamoto, Y.2
Sakurai, S.3
Watanabe, T.4
Yamamoto, H.5
-
36
-
-
42549147844
-
The RAGE pathway: Activation and perpetuation in the pathogenesis of diabetic neuropathy
-
DOI 10.1196/annals.1433.059, The Maillard Reaction Recent Advances in Food and Biomedical Sciences
-
Lukic IK, Humpert PM, Nawroth PP, Bierhaus A (2008) The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy. Ann NY Acad Sci 1126:76-80 (Pubitemid 351589321)
-
(2008)
Annals of the New York Academy of Sciences
, vol.1126
, pp. 76-80
-
-
Lukic, I.K.1
Humpert, P.M.2
Nawroth, P.P.3
Bierhaus, A.4
-
37
-
-
57149086451
-
Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors
-
Djordjević G, Matusan-Ilijas K, Sinozić E, Damante G, Fabbro D, Grahovac B, Lucin K, Jonjić N (2008) Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors. Croat Med J 49:608-617
-
(2008)
Croat Med J
, vol.49
, pp. 608-617
-
-
Djordjević, G.1
Matusan-Ilijas, K.2
Sinozić, E.3
Damante, G.4
Fabbro, D.5
Grahovac, B.6
Lucin, K.7
Jonjić, N.8
-
38
-
-
0034741661
-
WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells
-
Saile B, Matthes N, El Armouche H, Neubauer K, Ramadori G (2001) The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells. Eur J Cell Biol 80:554-561 (Pubitemid 32821626)
-
(2001)
European Journal of Cell Biology
, vol.80
, Issue.8
, pp. 554-561
-
-
Saile, B.1
Matthes, N.2
El, A.H.3
Neubauer, K.4
Ramadori, G.5
-
40
-
-
0142026785
-
Intervention against the Maillard reaction in vivo
-
Monnier VM (2003) Intervention against the Maillard reaction in vivo. Arch Biochem Biophys 419:1-15
-
(2003)
Arch Biochem Biophys
, vol.419
, pp. 1-15
-
-
Monnier, V.M.1
-
41
-
-
0035949502
-
Improved arterial compliance by a novel advanced glycation end-product crosslink breaker
-
Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG (2001) Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 104:1464-1470 (Pubitemid 32917336)
-
(2001)
Circulation
, vol.104
, Issue.13
, pp. 1464-1470
-
-
Kass, D.A.1
Shapiro, E.P.2
Kawaguchi, M.3
Capriotti, A.R.4
Scuteri, A.5
DeGroof, R.C.6
Lakatta, E.G.7
-
42
-
-
16244371321
-
The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure
-
DOI 10.1016/j.cardfail.2004.09.010
-
Little WC, Zile MR, Kitzman DW, Hundley WG, O'Brien TX, Degroof RC (2005) The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. J Card Fail 11:191-195 (Pubitemid 40462421)
-
(2005)
Journal of Cardiac Failure
, vol.11
, Issue.3
, pp. 191-195
-
-
Little, W.C.1
Zile, M.R.2
Kitzman, D.W.3
Hundley, W.G.4
O'Brien, T.X.5
Degroof, R.C.6
-
43
-
-
33846849277
-
Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension
-
DOI 10.1097/HJH.0b013e328013e7dd, PII 0000487220070300000015
-
Zieman SJ, Melenovsky V, Clattenburg L, Corretti MC, Capriotti A, Gerstenblith G, Kass DA (2007) Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens 25:577-583 (Pubitemid 46213796)
-
(2007)
Journal of Hypertension
, vol.25
, Issue.3
, pp. 577-583
-
-
Zieman, S.J.1
Melenovsky, V.2
Clattenburg, L.3
Corretti, M.C.4
Capriotti, A.5
Gerstenblith, G.6
Kass, D.A.7
|